GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Cyclically Adjusted PB Ratio

WPD Pharmaceuticals (XCNQ:WBIO) Cyclically Adjusted PB Ratio : (As of May. 17, 2024)


View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


WPD Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for WPD Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Cyclically Adjusted PB Ratio Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.32 5.28 12.77 17.09 -

WPD Pharmaceuticals Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.09 88.95 - - -

Competitive Comparison of WPD Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, WPD Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WPD Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WPD Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where WPD Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



WPD Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

WPD Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, WPD Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.005/125.0724*125.0724
=-0.005

Current CPI (Dec. 2023) = 125.0724.

WPD Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201310 0.010 97.182 0.013
201401 -0.001 97.261 -0.001
201404 -0.009 98.920 -0.011
201407 -0.017 99.315 -0.021
201410 -0.023 99.473 -0.029
201501 -0.012 98.209 -0.015
201504 -0.013 99.710 -0.016
201507 0.000 100.579 0.000
201510 0.000 100.500 0.000
201601 -0.021 100.184 -0.026
201604 -0.022 101.370 -0.027
201607 -0.031 101.844 -0.038
201610 -0.047 102.002 -0.058
201701 -0.093 102.318 -0.114
201704 -0.119 103.029 -0.144
201707 -0.142 103.029 -0.172
201710 0.014 103.424 0.017
201801 0.018 104.056 0.022
201804 0.009 105.320 0.011
201807 0.146 106.110 0.172
201810 0.142 105.952 0.168
201901 0.030 105.557 0.036
201904 0.026 107.453 0.030
201907 0.019 108.243 0.022
201910 0.014 107.927 0.016
202003 0.029 107.927 0.034
202006 0.026 108.401 0.030
202009 0.022 108.164 0.025
202012 0.010 108.559 0.012
202103 0.000 110.298 0.000
202106 -0.010 111.720 -0.011
202109 -0.018 112.905 -0.020
202203 0.000 117.646 0.000
202206 0.000 120.806 0.000
202209 0.000 120.648 0.000
202212 -0.004 120.964 -0.004
202303 -0.005 122.702 -0.005
202306 -0.005 124.203 -0.005
202309 -0.006 125.230 -0.006
202312 -0.005 125.072 -0.005

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


WPD Pharmaceuticals  (XCNQ:WBIO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


WPD Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


WPD Pharmaceuticals (XCNQ:WBIO) Business Description

Traded in Other Exchanges
N/A
Address
750 West Pender Street, Suite 401, Vancouver, BC, CAN, V6C 2T7
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, research, and development of medicinal products involving biological compounds and small molecules. The company has eight novel drug candidates which are in clinical development and pre-clinical development stage.

WPD Pharmaceuticals (XCNQ:WBIO) Headlines

No Headlines